ATE405666T1 - Verfahren zur herstellung eines beta-hydroxy- delta-lactons mittels neuer zwischenprodukte - Google Patents
Verfahren zur herstellung eines beta-hydroxy- delta-lactons mittels neuer zwischenprodukteInfo
- Publication number
- ATE405666T1 ATE405666T1 AT01103845T AT01103845T ATE405666T1 AT E405666 T1 ATE405666 T1 AT E405666T1 AT 01103845 T AT01103845 T AT 01103845T AT 01103845 T AT01103845 T AT 01103845T AT E405666 T1 ATE405666 T1 AT E405666T1
- Authority
- AT
- Austria
- Prior art keywords
- lactone
- delta
- beta
- hydroxy
- producing
- Prior art date
Links
- 239000013067 intermediate product Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- DFCBXXMUTYGNRI-VHSXEESVSA-N (4s,6r)-4-[tert-butyl(dimethyl)silyl]oxy-6-(hydroxymethyl)oxan-2-one Chemical compound CC(C)(C)[Si](C)(C)O[C@H]1C[C@H](CO)OC(=O)C1 DFCBXXMUTYGNRI-VHSXEESVSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01103845A EP1234884B1 (de) | 2001-02-16 | 2001-02-16 | Verfahren zur Herstellung eines Beta-Hydroxy-Delta-Lactons mittels neuer Zwischenprodukte |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE405666T1 true ATE405666T1 (de) | 2008-09-15 |
Family
ID=8176520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01103845T ATE405666T1 (de) | 2001-02-16 | 2001-02-16 | Verfahren zur herstellung eines beta-hydroxy- delta-lactons mittels neuer zwischenprodukte |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1234884B1 (de) |
| AT (1) | ATE405666T1 (de) |
| DE (1) | DE60135438D1 (de) |
| ES (1) | ES2311488T3 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0604483A1 (de) * | 1991-09-20 | 1994-07-06 | Zeneca Limited | Verfahren zur herstellung von enantiomeren reinen 4-hydroxytetrahydro-2-pyranon-derivaten |
-
2001
- 2001-02-16 EP EP01103845A patent/EP1234884B1/de not_active Expired - Lifetime
- 2001-02-16 AT AT01103845T patent/ATE405666T1/de not_active IP Right Cessation
- 2001-02-16 ES ES01103845T patent/ES2311488T3/es not_active Expired - Lifetime
- 2001-02-16 DE DE60135438T patent/DE60135438D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60135438D1 (de) | 2008-10-02 |
| EP1234884A1 (de) | 2002-08-28 |
| ES2311488T3 (es) | 2009-02-16 |
| EP1234884B1 (de) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2188661T3 (es) | Preparacion de un derivado de camptothecin por ciclacion intramolecular. | |
| DE69837615D1 (de) | Verfahren zur herstellung von oxazolidinonen | |
| DE69322708D1 (de) | Neues Verfahren zur Herstellung von 7-(substituierten)-9-[(substistuierter Glycyl)amido]-6-demethyl-6-deoxytetracyclinen | |
| DE602004019187D1 (de) | Verfahren zur herstellung verbesserter angedickter getränke gegen dysphagie | |
| DE60124692D1 (de) | Verfahren zur herstellung von optisch-aktiven sulfoxid-derivaten | |
| ATE407127T1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
| ATE521600T1 (de) | Verfahren zur herstellung von statinen | |
| ATE277915T1 (de) | Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen | |
| DE60125378D1 (de) | Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen | |
| ATE288891T1 (de) | Verfahren zur herstellung von amid-derivaten und ihren zwischenverbindungen | |
| DE60105314D1 (de) | Verfahren zur herstellung von taxanderivaten | |
| ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
| ATE405666T1 (de) | Verfahren zur herstellung eines beta-hydroxy- delta-lactons mittels neuer zwischenprodukte | |
| ATE172446T1 (de) | Verfahren zur herstellung von radiomarkierten meta-halobenzylguanidin | |
| ATE314377T1 (de) | Verfahren zur herstellung von cephalosporin- verbindungen und zwischenprodukte für die synthese dieser verbindungen | |
| DE60211303D1 (de) | Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| DE60107292D1 (de) | Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
| ATE223414T1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
| DE69812079D1 (de) | Verfahren zur herstellung eines buthylthuio-isochinolinderivates und zwischenprodukte dafür | |
| ATE277919T1 (de) | Verfahren zur herstellung von baccatin iii- derivativen | |
| EP1693358A4 (de) | Verfahren zur herstellung einer epoxytriazolverbindung und zwischenprodukt dafür | |
| ATE401298T1 (de) | Verbessertes verfahren zur herstellung von 2s,3s- n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)- - nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin | |
| ATE311375T1 (de) | Verfahren zur herstellung antiosteoporicagenz | |
| ATE265421T1 (de) | Verfahren zur herstellung von midodrin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |